about
The danger signal S100B integrates pathogen- and danger-sensing pathways to restrain inflammationAryl hydrocarbon receptor control of a disease tolerance defence pathwayThe cross-talk between opportunistic fungi and the mammalian host via microbiota's metabolism.Calcium and calcineurin-NFAT signaling regulate granulocyte-monocyte progenitor cell cycle via Flt3-L.Microbiota control of a tryptophan-AhR pathway in disease tolerance to fungi.Gene network inference using continuous time Bayesian networks: a comparative study and application to Th17 cell differentiation.Receptors and pathways in innate antifungal immunity: the implication for tolerance and immunity to fungi.Immunity and tolerance to Aspergillus fumigatus.Thymosin alpha1: an endogenous regulator of inflammation, immunity, and tolerance.IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses.Provision of antifungal immunity and concomitant alloantigen tolerization by conditioned dendritic cells in experimental hematopoietic transplantation.IL-17 and therapeutic kynurenines in pathogenic inflammation to fungi.Indoleamine 2,3-dioxygenase (IDO) in inflammation and allergy to Aspergillus.Th17 cells in the setting of Aspergillus infection and pathology.Indoleamine 2,3-dioxygenase in infection: the paradox of an evasive strategy that benefits the host.A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis.Non-hematopoietic cells contribute to protective tolerance to Aspergillus fumigatus via a TRIF pathway converging on IDO.Thymosin alpha1: the regulator of regulators?IL-22 in antifungal immunity.Systems biology of infectious diseases: a focus on fungal infections.Phagocytosis of Particulate Antigens - All Roads Lead to Calcineurin/NFAT Signaling Pathway.Tryptophan Feeding of the IDO1-AhR Axis in Host-Microbial Symbiosis.Learning from other diseases: protection and pathology in chronic fungal infections.Aryl Hydrocarbon Receptor-Dependent Pathways in Immune Regulation.NFATc2 mediates epigenetic modification of dendritic cell cytokine and chemokine responses to dectin-1 stimulation.Continuous time Bayesian networks identify Prdm1 as a negative regulator of TH17 cell differentiation in humansTh17/Treg imbalance in murine cystic fibrosis is linked to indoleamine 2,3-dioxygenase deficiency but corrected by kynurenines.The IL-17F/IL-17RC Axis Promotes Respiratory Allergy in the Proximal Airways.The yin-yang nature of CSF1R-binding cytokines.CD103(+) Dendritic Cells Control Th17 Cell Function in the Lung.Impaired calcineurin signaling in myeloid cells results in downregulation of pentraxin-3 and increased susceptibility to aspergillosis.Intranasally delivered siRNA targeting PI3K/Akt/mTOR inflammatory pathways protects from aspergillosis.IDO mediates TLR9-driven protection from experimental autoimmune diabetes.Genetic susceptibility to aspergillosis in allogeneic stem-cell transplantation.A crucial role for tryptophan catabolism at the host/Candida albicans interface.Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22.IL-17/Th17 in anti-fungal immunity: what's new?Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease.Immunity and tolerance to Aspergillus involve functionally distinct regulatory T cells and tryptophan catabolism.Functional yet balanced reactivity to Candida albicans requires TRIF, MyD88, and IDO-dependent inhibition of Rorc.
P50
Q33851482-DCDD6B59-8D95-47D7-A8D7-B96136F9026EQ33901562-BF179EEC-9059-4A4B-8914-08F235F0EDA1Q34448291-75344C7F-A609-4273-897B-8DAFBB3588C6Q34806661-2E6AC73B-F2A5-48FD-B11C-861FF6A349FAQ35277854-E40DF32B-B275-42EE-8052-0FBF9458FE34Q35509330-D2637F73-7C7B-4571-9A40-8EDC60D9269EQ36693529-88897BF9-07F9-4511-957F-1185AC86D3B4Q36728255-CCD322B4-AF46-4015-BF88-CA65D2D5B131Q36818200-8ADE9704-AD11-4F1E-9B79-6CC3DC7E8E6EQ36882237-0BF2F5E0-4B5C-4F77-ADE8-2FE26F0B23E5Q36934952-D6EC2C2F-DE39-4F7D-881B-AEB0CB9601ACQ37129200-6991ADC7-180D-4E20-953B-21BDC5280B62Q37209953-6893D40E-1461-493B-9735-8BFB89911E50Q37209967-53252435-403E-4F45-BB50-3C267C519842Q37325190-E6F654BF-FF69-42EA-B5E1-7D0BE6DBC325Q37591319-A4213D5C-D7B1-43F8-9D3C-93DAE9DCFA14Q37729196-98272BED-D4E7-4F8E-817B-99D7531E5EA3Q37763964-9A4C1C80-C43A-4292-80FB-2DBFCA1C434BQ37832449-FF807BC8-E711-4322-B8DB-59FFCDC5171AQ37926002-F08BE2C4-11B0-4BB6-921B-A8484014128AQ38177272-CFD50F40-C363-4DFD-9743-8A13321BBDAFQ38310249-B8AEF216-C38E-4A41-A337-85BA7A05B616Q38588803-FE687B03-A7C1-4A30-9B86-BBD9F634CECAQ38692038-31C5D56B-71C7-464D-959D-B3D6F5FA6BB4Q38924304-ACD59887-813B-4E21-B6DC-C36B0A9DA52AQ38997587-8DD16DB7-7076-4E84-BF37-0A8BD4E2322DQ39488014-EDEEA835-2794-4C2D-94F7-E69BB9A49407Q40091376-7138653C-6286-412E-94FE-2345F7D0C689Q40280062-6ED7D287-B59D-4A93-9DFC-DB3DC3192447Q41002824-B82576E7-AA7D-4072-8D8B-8203BA991A8FQ42103290-10BCE334-CB7A-4C4A-9F6D-3363152C492AQ43239054-BA52D18D-7F36-48C1-B39A-D3E9B39AF4BDQ43258639-9F6A1A83-D08E-4954-AC00-6D285FBD91B8Q45210371-28894FF1-03FE-46B9-98BE-C5EF31BD6B00Q45280823-951177EE-684B-4A7B-9C67-8B303AD90AD3Q45760347-3CF07B5F-7819-4C3C-9B30-9F703EC509E3Q46089935-E486B2E8-552B-44DA-8E31-689D5A3B4FBFQ46815296-16EA24C2-DC3D-44D0-8C93-B815C6DAB169Q46902191-06E074BB-7117-43B3-9B6E-1006C6233366Q46942144-4B0F91DE-CC75-419E-9984-9FC6B60349CD
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Teresa Zelante
@ast
Teresa Zelante
@en
Teresa Zelante
@es
Teresa Zelante
@nl
type
label
Teresa Zelante
@ast
Teresa Zelante
@en
Teresa Zelante
@es
Teresa Zelante
@nl
prefLabel
Teresa Zelante
@ast
Teresa Zelante
@en
Teresa Zelante
@es
Teresa Zelante
@nl
P106
P21
P31
P496
0000-0002-7071-0302